Scarica l'app Stockscreener
1.11
0.88%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.13
Aprire:
$1.13
Volume 24 ore:
26,622
Relative Volume:
0.59
Capitalizzazione di mercato:
$12.85M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-2.0943
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
+0.00%
1M Prestazione:
-1.72%
6M Prestazione:
+5.56%
1 anno Prestazione:
-34.86%
Intervallo 1D:
$1.10
$1.146
Intervallo di 1 settimana:
$1.10
$1.23
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.11 | 13.43M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
146.53 | 67.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.68 | 45.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.455 | 44.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.61 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.44 | 13.28B | 2.41B | 305.80M | 492.20M | 2.95 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
What is the risk reward ratio of investing in TherapeuticsMD Inc. stockDaily Trading Strategy For Smart Trading - jammulinksnews.com
What are analysts’ price targets for TherapeuticsMD Inc. in the next 12 monthsDaily Trading Opportunities For Consistent Profits - jammulinksnews.com
What recovery options are there for TherapeuticsMD Inc.In-Depth Stock Trading Volume Analysis - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningFree Pattern Alert With ROI Driven Strategy - Newser
TherapeuticsMD Inc. stock trend forecastLow Capital High Return Stock Plans Reviewed - metal.it
Analyzing TherapeuticsMD Inc. with risk reward ratio chartsAlpha Trade Flow With Risk Calibration - Newser
Using data tools to time your TherapeuticsMD Inc. exitCapital Safe Picks with Consistent Gains - Newser
Will TherapeuticsMD Inc. see short term momentumWeekly Trend Screener with Momentum Picks - Newser
Quant Tools Rank TherapeuticsMD Inc. as High Risk High RewardEntry Alert Based on Volume Spikes Detected - metal.it
Candlestick Signal Suggests Reversal in TherapeuticsMD Inc.Triple Digit Growth Focused Trade Plan Reviewed - metal.it
Why TherapeuticsMD Inc. stock attracts strong analyst attentionPre-Market Stock Movement Summary and Review - Newser
What makes TherapeuticsMD Inc. stock price move sharplyMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-07-30 00:06:51 - metal.it
Using flow based indicators on TherapeuticsMD Inc.Real-Time Analysis With Entry Targets In Progress - metal.it
TherapeuticsMD Inc. Stock Flags Risk Zone in Volatility IndexStep-by-Step Trade Signal Implementation Guide Ready - metal.it
Custom watchlist performance reports with TherapeuticsMD Inc.Momentum Detection with Entry Optimization - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Free Conservative Long Term Growth Plans - Newser
How TherapeuticsMD Inc. stock performs during market volatilityMomentum Screener with Buy and Sell Areas - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysFree ROI Boosting Trade Opportunity Calendar - Newser
TherapeuticsMD Inc. Crosses 200 Day MA — Signal or NoiseFast Exit and Entry Strategy Guide Offered - metal.it
TherapeuticsMD Inc. Flashes Buy Signal on Multi Timeframe ChartEntry Alert With Low Drawdown Strategy Noted - metal.it
When is TherapeuticsMD Inc. stock expected to show significant growthInvest confidently with actionable market data - jammulinksnews.com
How to interpret RSI for TherapeuticsMD Inc. stockReliable Setup Screener with Low Risk - Newser
Should I hold or sell TherapeuticsMD Inc. stock in 2025Expert guidance for superior capital growth - jammulinksnews.com
Published on: 2025-07-28 06:06:00 - jammulinksnews.com
What are the latest earnings results for TherapeuticsMD Inc.Access high-yield investment alerts now - jammulinksnews.com
Is TherapeuticsMD Inc. a growth stock or a value stockUnlock real-time stock alerts for quick profits - jammulinksnews.com
Is TherapeuticsMD Inc. a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
What analysts say about TherapeuticsMD Inc. stockFree Stock Movement Tracking - Autocar Professional
What drives TherapeuticsMD Inc. stock priceRecord-breaking gains - PrintWeekIndia
Is TherapeuticsMD Inc. stock overhyped or has real potentialTremendous return on equity - jammulinksnews.com
TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
| Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
| Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
0.46%
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):